The synergistic effect of 5-hydroxytryptamine and epinephrine on the human platelet is related to the activation of phospholipase C

Eur J Pharmacol. 1993 May 15;245(3):273-80. doi: 10.1016/0922-4106(93)90107-k.

Abstract

Simultaneous addition of 5-hydroxytryptamine (5-HT) and epinephrine synergistically elevated cytosolic free Ca2+ concentration ([Ca2+]cyt) and activated phospholipase C. These phenomena occurred in an agonist concentration-dependent manner and reflected an increase in maximal response rather than a, shift in affinity for either of the stimuli. Ketanserin, a 5HT2 receptor antagonist completely blocked the response of 5-HT plus epinephrine and this in the nanomolar concentration range in which the drug selectively antagonizes 5-HT2 receptor-mediated responses. The synergistic effect was not a consequence of the activation by the platelet-release products ADP and 5-HT nor of influx of extracellular Ca2+. It is concluded that an increased activation of phospholipase C plays a major role in provoking the synergistic effects between 5-HT and epinephrine at the level of signal transduction.

MeSH terms

  • Adenosine Diphosphate / blood
  • Blood Platelets / drug effects*
  • Blood Platelets / metabolism
  • Calcium / blood
  • Chromatography, Gel
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Enzyme Activation
  • Epinephrine / pharmacology*
  • Humans
  • In Vitro Techniques
  • Ketanserin / pharmacology
  • Serotonin / pharmacology*
  • Signal Transduction
  • Type C Phospholipases / blood
  • Type C Phospholipases / metabolism*

Substances

  • Serotonin
  • Adenosine Diphosphate
  • Ketanserin
  • Type C Phospholipases
  • Calcium
  • Epinephrine